Long-term follow up of patients with follicular lymphoma (FL) receiving high dose therapy (HOT) with autologous haematopoietic progenitor cell support at St. Bartholomew's Hospital (SBH).

被引:0
|
作者
Davies, AJ [1 ]
Apostolidis, J [1 ]
Micallef, IN [1 ]
Montoto, S [1 ]
Matthews, J [1 ]
Lister, TA [1 ]
Rohatiner, AZS [1 ]
机构
[1] St Bartholomews Hosp, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:577S / 577S
页数:1
相关论文
共 50 条
  • [41] High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results
    Carella, Angelo Michele
    Bellei, Monica
    Brice, Pauline
    Gisselbrecht, Christian
    Visani, Giuseppe
    Colombat, Philippe
    Fabbiano, Francesco
    Donelli, Amedea
    Luminari, Stefano
    Feugier, Pierre
    Browett, Peter
    Hagberg, Hans
    Federico, Massimo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 146 - 148
  • [42] A PHASE I/II STUDY OF CYCLOPHOSPHAMIDE AND TOPOTECAN IN PATIENTS WITH HIGH-RISK MALIGNANCIES UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE ST. JUDE LONG-TERM FOLLOW-UP
    Kasow, K. A.
    Barfield, R. C.
    Wrigbt, N. L.
    Li, C.
    Srivastava, D. K.
    Horwitz, E. M.
    Leung, W.
    Woodard, P.
    Bowman, L. C.
    Handgretinger, R.
    Hale, G. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 72 - 73
  • [43] To the editor: Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation
    Wiesmann, A
    Weissert, R
    Kanz, L
    Einsele, H
    BLOOD, 2002, 100 (07) : 2679 - 2680
  • [44] Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience
    U De Giorgi
    G Rosti
    G Papiani
    M Marangolo
    Bone Marrow Transplantation, 2004, 33 : 639 - 643
  • [45] Long-term follow-up of 100 patients undergoing high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for Hodgkin's disease (HD).
    Forrest, DL
    Nevill, TJ
    Connors, JM
    Shepherd, JD
    Nantel, SH
    Sutherland, HJ
    Hogge, DE
    Toze, CL
    Barnett, MJ
    BLOOD, 1997, 90 (10) : 2636 - 2636
  • [46] Long-term follow-up in patients with advanced Hodgkin's disease treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation
    Bragotti, LZ
    Colombo, AA
    Bernasconi, P
    Caldera, D
    Brusamolino, E
    Baratè, C
    Bonfichi, M
    Maffioli, M
    Zaniboni, AA
    Algarotti, A
    Troletti, D
    Lazzarino, M
    Alessandrino, E
    BONE MARROW TRANSPLANTATION, 2006, 37 : S241 - S241
  • [47] Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma
    Cassaday, Ryan D.
    Stevenson, Philip A.
    Gooley, Theodore A.
    Chauncey, Thomas
    Pagel, John
    Till, Brian G.
    Philip, Mary
    Orozco, Johnnie J.
    Bensinger, William I.
    Holmberg, Leona
    Shustov, Andrei R.
    Green, Damian J.
    Smith, Stephen D.
    Libby, Edward N.
    Maloney, David G.
    Soma, Lorinda A.
    Press, Oliver W.
    Gopal, Ajay K.
    BLOOD, 2014, 124 (21)
  • [48] Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience
    De Giorgi, U
    Rosti, G
    Papiani, G
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2004, 33 (06) : 639 - 643
  • [49] Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells
    Witzens-Harig, Mathias
    Heilmann, Conny
    Hensel, Manfred
    Kornacker, Martin
    Benner, Axel
    Haas, Rainer
    Fruehauf, Stefan
    Ho, Anthony D.
    STEM CELLS, 2007, 25 (01) : 228 - 235
  • [50] Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)
    Metzner, Bernd
    Casper, Jochen
    Claus-Henning, Koehne
    Renzelmann, Andrea
    Mueller, Thomas H.
    Petershofen, Eduard K.
    Rosien, Bernd
    Thole, Ruth
    Voss, Andreas
    Dreyling, Martin H.
    Hoster, Eva
    Klapper, Wolfram
    Pott, Christiane
    BLOOD, 2019, 134